Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-05
1998-04-07
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
264 41, 264 43, A61K 9127
Patent
active
057361550
ABSTRACT:
Methods for encapsulating ionizable antineoplastic agents in liposomes using transmembrane potentials are provided. Trapping efficiencies approaching 100% and rapid loading are readily achieved. Dehydration protocols which allow liposomes to be conveniently used in the administration of antineoplastic agents in a clinical setting are also provided. In accordance with other aspects of the invention, transmembrane potentials are used to reduce the rate of release of ionizable drugs from liposomes.
REFERENCES:
patent: 3962429 (1976-06-01), Furuno et al.
patent: 3993754 (1976-11-01), Rahman et al.
patent: 4016100 (1977-04-01), Suzuki et al.
patent: 4193983 (1980-03-01), Ullman et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4247344 (1981-01-01), Vanlerberghe et al.
patent: 4370349 (1983-01-01), Evans et al.
patent: 4372949 (1983-02-01), Kodama et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4397846 (1983-08-01), Weiner et al.
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4419348 (1983-12-01), Rahman et al.
patent: 4438052 (1984-03-01), Weder et al.
patent: 4460577 (1984-07-01), Moro et al.
patent: 4485045 (1984-11-01), Regen
patent: 4515736 (1985-05-01), Deamer
patent: 4529561 (1985-07-01), Hunt et al.
patent: 4532089 (1985-07-01), MacDonald et al.
patent: 4769250 (1988-09-01), Forssen
patent: 4880635 (1989-11-01), Janoff et al.
patent: 4885172 (1989-12-01), Bally et al.
patent: 4891208 (1990-01-01), Janoff et al.
patent: 4946683 (1990-08-01), Forssen
patent: 5047245 (1991-09-01), Bally et al.
patent: 5077056 (1991-12-01), Ballet et al.
Abra, et al., 1983, Cancer Chemother. Pharmacol, 11:98, "Delivery of Therapeutic Doses of Doxorubicin in the Mouse Lung Using Lung-Accumulating Liposomes Proves Unsuccessful".
Akerman, et al., 1976, Biochim. Biophys. Acta., 426:624, "Staching of Safranine in Liposomes During Valinomycin Induced Efflux of Potassium Ions".
Bally, et al., 1985, Biochim. Biophys. Acta., 812:66, "Uptake of Saframine and Other Lipophilic Cations into Model Membrane System in Response to a Membrane Potential".
Bottcher, et al. 1961 Anal. Chim. Acta., 24:203-204, "A Rapid and Sensitive Sub-Micro Phosphorus Determination".
Burke et al., Chem. Abstracts, vol. 102, No. 3, Jan. 21, 1985.
Cafisco, et al., 1983, Biophys, J. 44:49, "Electrogenic H+/OH--Movement Accorss Phospholipid Vesicles Measured by Spin-Labeled Hydrophobic Ions".
Casey et al., "Active Proton Uptake by Chromaffin Granules: Observation by Amine Distribution and Phosphorus-31 Nuclear Magnetic Resonance Techniques", 1977 Biochemistry 16(5) pp. 972-976.
Chemical Abstracts 103:174355e.
Chemical Abstracts 99:49240m.
Chen, et al., 1956, Analytical Chem., 11:1756-1758, "Microdetermination of Phosphorus".
Corda, et al., J. Membr. Bio., 1982 65(3) 235-42, "Increase in Lipid Microviscosity of Unilamellar Vesicles upon the Creation of Transmembrane Potential", Chem. Abs. vol. 96, 1982, Abs. 176569p.
Cramer and Prestegard, "NMR Studies of pH-Induced Transport of Carboxylic Acids Across Phospholipid Vesicle Membranes", Biochem. Biophys Res. Commun. 1977, 175(2) pp. 295-301.
Crommelin, et al. Preparation and Characterization of Doxorubicin-containing liposomes II. Capacity. Long Term Stability and Doxorubicin-bilayer interaction mechanism, Abst. 109032w., Int. J. Pharm. 1983, 17(2-3) 135-44.
Kornberg, et al., "Measurement of Transmembrane Potentials in Phospholipid Vesicles", 1972, Proc. Nat. Aca. Sci, USA 69(6), pp. 1508-1513.
Lenk, et al., "Stabilized Purilamellar Vesicles: A New Type of Liposome", Abstract No. 83980x.
Lenk, et al. Stable plurilamellar vesicles, Chamical Abstracts, vol. 100, 1984., 215560b.
Mauk, et al., 1979, PNAS, USE 76:765, "Preparation of Lipid Vesicles Containing High Levels of Entrapped Radioactive Cations".
Mayhew et al., Biol. Cell (1981) 1983 47(1) 81-5, Chem. Abs. vol. 98, 1983, Abs. 221734t.
Mayer, et al.,Chemical Abstracts 103:76141n.
McLaughlin et al., J. Gen. Physiol. 1981, 77(4) 445-73, Chemical Abs. vol. 94, 1981, Abstract 169846g.
Morii, et al., 1983, Int. J. Pharm. 17(2-3), 215-224, "Size and Permeability of Liposomes Extruded Through Polycarbonate Membranes".
Moro, et al., "Purification of Liposome Suspension",, Chem. Abstract, vol. 94, 1981, 52931a.
Nichols, et al., 1976, Biochim. Biophys. Acta., 455:269, "Catecholamine Uptake and Concertration by Liposomes Maining pH Gradients".
Olson, Eur. J. Cancer Clin. Oncol., 18:167, "Characterization, Toxicity and Therapeutic Efficacy of Adriamycin Encapsulated in Liposomes".
Papahadjopoulos, et al, 1980, in Liposomes and Immunology, 1980, Tom and Six, eds., Elsevier, New York, "Optimization of Liposomes as a Carder System for the Intracellular Delivery of Drugs and Macromolecules".
Pick, 1981, Arch. Biochem. Biophuys., 212(1), 186-194, "Liposomes with a Large Trappping Capacity Prepared by Freezing and Thawing of Sonicated Phospholipid Mixtures".
Rahman, et a., 1982 Cancer Res. 42:1817, "Doxorubicin-Induced Chronic Cardiotoxicity and Its Protection by Lipsomal Administration".
Rosa, et al., 1982, in: Transport in Biomembranes, 1982, R. Antolini et al., (ed.), Raven Press, New York, "Liposomes Containing Doxorubicin: An Exmple of Drug Targeting".
Rosa, et al., 1983 Pharmacol., 26:221, "Absorption and Tissue Distribution of Doxorubicin Entrapped in Liposomes Following Intraveous or Intraperitoneal Administration".
Crommelin, et al., 1983, Int. J. Pharm. 16(1):79 "Preparation and Characterization of Doxorubicin-Containing Liposomes: I. Influence of Liposome Charge and pH of Hydration Medium on Loading Capactity and Particle Size".
Crommelin, et al., "Stability of Liposomes on Storage: Freeze Dried, Frozen or as an Aqueous Dispersions", Phar. Res. (1984) pp. 159-163 .
Deamer, 1983, in: Liposomes, 1983, M. Ostro (ed.), Marcel Dekker, New York.
Deamer, et al., "The Response of Fluorescent Amines to pH Gradients Across Liposome Membranes", 1972, Biochemi. Biophys. Acta, 274, pp. 323-335.
Forssen, et al., 1983, Cancer Res., 43:546, "Improved Therapeutic Benefits of Doxorubicin by Entrapment in Anionic Liposomes".
Gabizon, et al., 1982, Cancer Res. 42-4734, "Liposomes as in Vivo Carriers of Adriamycin:Reduced Cardiac Uptake and Preserved Antitumor Activity in Mice".
Garcia, et al., 1983, Biochemistry 22(10):2524, "Mechanism of Lactose Translocation in Proteoliposomes Reconstituted with Iac Carrier Protein Purified from Escherichia coli. 1. Effect of pH and Imposed Membrane Potential on Efflux, Exchange, and Counterflow".
Herbette, et al., Chem. Abstracts, vol. 102, No. 3, Jan. 21, 1985.
Hope, et al., 1987, Biochim. Biophys. Acta., 812:55, "Production of Large Unilamellar Vesciles by a Rapid Extrusion Proceudre. Characterization of Size Distribution, Trapped Volume and Ability to Maintain a Membrane Potention".
Jonah, et al., 1975, Biochim, et Biophys. Acta 401:336-348, "Tissue Distribution of EDTA Encapsulated Within Liposomes of Varying Surface Properties".
Kano, et al., 1977, Life Sciences, 20:1729, "Enhanced Uptake of Drugs in Liposomes" Use of Labile Vitamin B12 Complexes of 6-Mercaptopurine and 8-Azaguardne.
Kano and Fendler, "Pyranine as a Sensitive pH Probe for Liposome Interiors and Surfaces", Biochemic. Biophys Acta. 1978, 509, pp. 289-299.
Kirby and Gregoriadis, "The Effect of Lipid Composition of Small Unilamellar Liposomes Containing Melphalan and Vincristine on Drug Clearance After Injection into Mice", Abstract of Biochem. Pharmacol. 1983, 32(4) pp. 609-615.
Kirby, et al., 1984 in Liposome Technology, vol. 1, Preparation of Liposomes, G. Gregoriadias, et. pp. 19-27, "A Simple Procedure for Preparing Liposomes Capable of High Encapsultion Efficiency Under Mild Conditions".
Kirby, et al., 1984, Bio/Technology, 2(11):979, "Dehydration-Rehydration Vesicles": A Simple Method for High Yield Drug Entrapment in Liposomes.
Shakhov, et al., 1984, Biokhimika, 48(8):1347, "Reconstitution of Highly Purified Proton-Translocating Pyrothosphatas".
Singleton, et al., 1965, J. Am Oil Chem. Soc. 42:53-56, "Chromatographically Homogeneous Lecithin from Egg Phospholipids"
Bally Marcel B.
Cullis Pieter R.
Hope Michael J.
Madden Thomas D.
Mayer Lawrence D.
Kishore Gollamudi S.
Rubin Kenneth B.
The Liposome Company Inc.
LandOfFree
Encapsulation of antineoplastic agents in liposomes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Encapsulation of antineoplastic agents in liposomes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulation of antineoplastic agents in liposomes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-10471